Lifeforce Capital is a venture capital firm that invests in software companies reshaping the status quo in healthcare's largest markets. The firm focuses on software-driven companies and software-first techbio platforms that improve care delivery and enable more efficient therapeutic development.
34% of their portfolio is in Biotech & Life Sciences. They made 3 investments in the last 12 months. Their most common stage is series-a (53% of deals). Average disclosed round size is $42.9M (across 34 rounds with reported amounts).
Portfolio
31
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
JN
John Noonan
Managing Partner
AP
Adam Pelavin
Partner
SB
Sudhir Bahl
Founder & CEO
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
38 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 CareCubes | Series A | $6.5M | Mar 2026 |
 Aspen Neuroscience | Series C | $115M | Nov 2025 |
 Aspen Neuroscience | Series C | $115M | Nov 2025 |
 Vilya Therapeutics | Series A | $71M | Jun 2024 |
 Vilya | Series A | $71M | Jun 2024 |
 Ochre Bio | Series A | $30M | Oct 2022 |
 Mindright | Seed | — | Jun 2022 |
| Aspen Neuroscience | Series B | $147.5M | May 2022 |
| Aspen Neuroscience | Series B | — | May 2022 |
 Synapticure | Seed | $6M | Feb 2022 |
 Postera | Series A | $24M | Jan 2022 |
 64x Bio | Series A | $55M | Jan 2022 |
 Fauna Bio | Seed | $9M | Sep 2021 |
| FFauna | Unknown | $9M | Sep 2021 |
 Sonoma Biotherapeutics | Series B | $265M | Aug 2021 |
 Bayesian Health | Unknown | $15M | Jul 2021 |
 Sitka | Series A | $14M | Feb 2021 |
 Sitka | Series A | $14M | Feb 2021 |
 Sitka | Series A | $14M | Jan 2021 |
 Vivante Health | Series A | $16M | Jan 2021 |
 Mythic Therapeutics | Series B | $103M | Jan 2021 |
 SEMPRE | Series B | $15M | Jan 2021 |
| Sonoma Biotherapeutics | Series A | $30M | Sep 2020 |
 Tara Biosystems | Series A | $10M | Jun 2020 |
 Vineti | Series C | $35M | Feb 2020 |
Page 1 of 2
Top Co-Investors
First Round Capital7 shared
ARCH Venture Partners7 shared
Y Combinator7 shared
GV6 shared
S325 shared
Alexandria Venture Investments5 shared
Canaan Partners4 shared
OrbiMed4 shared
LYFE Capital4 shared
Revelation Partners4 shared
Venrock4 shared
8VC3 shared
Menlo Ventures3 shared
BoxGroup3 shared
Casdin Capital3 shared
Kite, a Gilead Company3 shared
Frazier Life Sciences3 shared
Mirae Asset3 shared
Refactor Capital3 shared
Homebrew3 shared
Last updated: 20 October 2026